Back to Journals » Drug Design, Development and Therapy

Drug Design, Development and Therapy

ISSN: 1177-8881


Editor-in-Chief: Prof. Dr. Frank Boeckler

An international, peer-reviewed, open access journal that spans the spectrum of drug design and development through to clinical applications. The journal is characterized by the rapid reporting of application notes, reviews, original research and clinical studies in all therapeutic areas. Clinical outcomes, patient safety, and programs for the development and effective, safe, and sustained use of medicines will be a feature of the journal. 

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).

Latest articles:

- 5 records -

Comparison of the Efficacy of Anti-Obesity Medications in Real-World Practice

Song JE, Ko HJ, Kim AS

Drug Design, Development and Therapy 2024, 18:845-858

Published Date: 18 March 2024

Understanding Sorafenib-Induced Cardiovascular Toxicity: Mechanisms and Treatment Implications

Li J, Zhang L, Ge T, Liu J, Wang C, Yu Q

Drug Design, Development and Therapy 2024, 18:829-843

Published Date: 18 March 2024

Development and Characterization of a Novel Carbon-11 Labeled Positron Emission Tomography Radiotracer for Neuroimaging of Sirtuin 1 with Benzoxazine-Based Compounds

Wang Y, Liu Y, Wang Y, Bai P, Hallisey MR, Varela BL, Siewko A, Wang C, Xu Y

Drug Design, Development and Therapy 2024, 18:819-827

Published Date: 15 March 2024

Model-Informed Precision Dosing of Isoniazid: Parametric Population Pharmacokinetics Model Repository

Ju G, Liu X, Yang W, Xu N, Chen L, Zhang C, He Q, Zhu X, Ouyang D

Drug Design, Development and Therapy 2024, 18:801-818

Published Date: 14 March 2024


Read more articles